Advanced Cardiovascular Life Support (ACLS) Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The ACLS Market Report Segments the Industry Into by Technique (Airway Management, Electrotherapy, and More), by Product Type (Devices, Accessories), by Algorithm (Cardiac Arrest, Acute Coronary Syndromes, and More), by End User (Hospitals and Clinics, Emergency Medical Services, and More), and Geography (North America, Europe, and More).

Advanced Cardiovascular Life Support (ACLS) Market Size and Share

Advanced Cardiovascular Life Support (ACLS) Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Benchmark Advanced Cardiovascular Life Support (ACLS) Against Other Healthcare Markets

Advanced Cardiovascular Life Support (ACLS) Market Analysis by Mordor Intelligence

The Advanced Cardiovascular Life Support Market size is projected to expand from USD 8.5 billion in 2026 and USD 9.25 billion in 2027 to USD 14.08 billion by 2032, registering a CAGR of 8.77% between 2027 and 2032.

ACLS (Advanced Cardiovascular Life Support) utilizes evidence-based medical procedures to manage life-threatening emergencies, such as cardiac arrest, stroke, and trauma. By adhering to structured algorithms, ACLS aims to stabilize patients and restore vital signs and alertness. Several factors, such as the rising prevalence of chronic cardiovascular conditions, and technological advancements are likely to drive the market growth. Additionally, a growing focus on early and effective cardiac care, supported by public awareness campaigns and training protocols, significantly contributes to market growth during the forecast period.

The advanced cardiovascular life support (ACLS) market is experiencing notable growth, fueled by high cardiac procedural volumes. The increasing prevalence of cardiovascular diseases, such as heart attacks, strokes, and arrhythmia, necessitates a higher demand for cardiac procedures like advanced airway management, defibrillation, etc. For instance, the German Heart Surgery Report 2023 shared insights from a voluntary registry maintained by the German Society for Thoracic and Cardiovascular Surgery (DGTHG). This registry reported 168,841 cardiovascular procedures conducted in 2023 in the country. Of these, 19,699 pacemaker and implantable cardioverter defibrillator procedures accounted for 99.2%. Additionally, 2,982 extracorporeal life support and extracorporeal membrane oxygenation implantations were recorded, highlighting the growing adoption of mechanical circulatory support systems. Hence, the high number of cardiac procedures is likely to drive the adoption of ACLS training and technologies in hospitals and clinics during the forecast period.

Furthermore, major players are swiftly embracing cutting-edge strategies, including the adoption of novel technologies, a move expected to propel market expansion. For instance, in September 2024, Apollo Hospitals in Hyderabad, India, successfully treated the first-ever survivor of the E-CPR (extracorporeal cardiopulmonary resuscitation) procedure. E-CPR employs ECMO (extracorporeal membrane oxygenation), a vital technique that temporarily takes over the functions of both the heart and lungs. The availability of advanced technologies within cardiovascular care is expected to boost the growth of the market in the coming years.

Therefore, owing to factors such as increasing prevalence of cardiovascular diseases and advancements in medical technology, the advanced cardiovascular life support market is anticipated to witness significant growth over the forecast period. However, the high cost of ACLS devices and training, lack of skilled professionals, and low accessibility in low-income countries are expected to limit the market growth.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

Market Concentration

Advanced Cardiovascular Life Support (ACLS) Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The advanced cardiovascular life support (ACLS) market is fragmented in nature due to the presence of several companies operating globally as well as regionally. Leading companies shaping the advanced cardiovascular life support market include both global players and notable local firms. Key participants are developing and launching novel products and technologies to compete with existing products, while others are acquiring and partnering with other companies trending in the market. CPR Medical Devices, Inc., Abbott, and Michigan Instruments stand out as key players, collaborating with industry giants such as GE HealthCare, Nasco Healthcare Inc., and Boston Scientific Corporation. Furthermore, Koninklijke Philips N.V., Stryker, Asahi Kasei Corporation, ZOLL Medical Corporation, and Naugra Medical, among others, play a pivotal role in shaping the market landscape.

Advanced Cardiovascular Life Support (ACLS) Industry Leaders

  1. CPR Medical Devices, Inc.

  2. Abbott

  3. GE HealthCare

  4. Koninklijke Philips N.V.

  5. Stryker

  6. *Disclaimer: Major Players sorted in no particular order

Advanced Cardiovascular Life Support (ACLS) Market Companies Covered in this Report

  • CPR Medical Devices, Inc.
  • Abbott Laboratories
  • Michigan Instruments
  • GE Healthcare
  • Nasco Healthcare Inc.
  • Boston Scientific
  • Koninklijke Philips
  • Stryker
  • Asahi Kasei Corporation.
  • Zoll Medical
  • Naugra Medical

Recent Industry Developments in Advanced Cardiovascular Life Support (ACLS) Market

  • October 2024: Boston Scientific Corporation secured United States Food and Drug Administration (FDA) approval for its navigation-enabled FARAWAVE NAV Ablation Catheter, targeting the treatment of paroxysmal atrial fibrillation (AF). Additionally, the company received FDA 510(k) clearance for its new FARAVIEW Software. These innovations will enhance visualization during cardiac ablation procedures, working in tandem with the FARAPULSE Pulsed Field Ablation (PFA) System.
  • October 2024: Abbott announced key progress in its pulsed field ablation (PFA) solutions, including the early completion of enrollment for the VOLT-AF IDE Study supporting the Volt PFA System and the launch of the FOCALFLEX trial to evaluate the TactiFlex Duo Ablation Catheter, Sensor Enabled (SE), for treating paroxysmal atrial fibrillation.

Table of Contents for Advanced Cardiovascular Life Support (ACLS) Industry Report

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Value Chain / Supply Chain Analysis
  • 4.5 Porters 5 Force Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry
  • 4.6 PESTLE Analysis

5. MARKET SEGMENTATION

  • 5.1 By Technique
    • 5.1.1 Airway Management
    • 5.1.2 Electrotherapy
    • 5.1.3 Non-invasive Airway
    • 5.1.4 Endotracheal Intubation
    • 5.1.5 Cardiopulmonary Resuscitation (CPR)
    • 5.1.6 Lethal Arrythmias
    • 5.1.7 Others
  • 5.2 By Product Type
    • 5.2.1 Devices
    • 5.2.2 Accessories
  • 5.3 By Algorithm
    • 5.3.1 Cardiac Arrest
    • 5.3.2 Acute Coronary Syndromes
    • 5.3.3 Bradycardia
    • 5.3.4 Tachycardia
    • 5.3.5 Suspected Stroke Algorithms
    • 5.3.6 Others
  • 5.4 By End User
    • 5.4.1 Hospitals and Clinics
    • 5.4.2 Emergency Medical Services
    • 5.4.3 Medical Training Centers
    • 5.4.4 Others
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Vendor Market Share
  • 6.2 Mergers & Acquisitions
  • 6.3 Company Profiles
    • 6.3.1 CPR Medical Devices, Inc.
    • 6.3.2 Abbott
    • 6.3.3 Michigan Instruments
    • 6.3.4 GE HealthCare
    • 6.3.5 Nasco Healthcare Inc.
    • 6.3.6 Boston Scientific Corporation
    • 6.3.7 Koninklijke Philips N.V.
    • 6.3.8 Stryker
    • 6.3.9 Asahi Kasei Corporation.
    • 6.3.10 ZOLL Medical Corporation
    • 6.3.11 Naugra Medical
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Global Advanced Cardiovascular Life Support (ACLS) Market Report Scope

As per the scope of the report, advanced life support (ALS), commonly known as advanced cardiovascular life support (ACLS), encompasses a series of clinical interventions and protocols used to manage life-threatening cardiac emergencies, such as cardiac arrest, heart attack, and strokes. These go beyond the foundational basic life support (BLS) techniques, offering urgent interventions aimed at stabilizing patients and restoring normal heart rhythms.  

The advanced cardiovascular life support (ACLS) market is segmented by technique, product type, algorithm, end-user, and geography. By technique, the market is segmented into airway management, electrotherapy, non-invasive airway, endotracheal intubation, cardiopulmonary resuscitation (CPR), lethal arrythmias, and others. The other techniques include oxygen therapy, catheter placement, etc. By product type, the market is segmented into devices and accessories. By algorithm, the market is segmented into cardiac arrest, acute coronary syndromes, bradycardia, tachycardia, suspected stroke algorithms, and others. The other algorithm includes allergic reactions, trauma and injuries, etc. By end-user, the market is segmented into hospitals and clinics, cardiac catheterization labs, medical training centers, and others. The other end-user includes emergency medical services and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. For each segment, the market sizing and forecasts have been done based on revenue (USD). 

Segmentation Overview

By Technique
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
Airway Management
Electrotherapy
Non-invasive Airway
Endotracheal Intubation
Cardiopulmonary Resuscitation (CPR)
Lethal Arrythmias
Others
By Product Type
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
Devices
Accessories
By Algorithm
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
Cardiac Arrest
Acute Coronary Syndromes
Bradycardia
Tachycardia
Suspected Stroke Algorithms
Others
By End User
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
Hospitals and Clinics
Emergency Medical Services
Medical Training Centers
Others
Geography
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Advanced Cardiovascular Life Support (ACLS) Market segmentation breakdown
By Technique Airway Management
Electrotherapy
Non-invasive Airway
Endotracheal Intubation
Cardiopulmonary Resuscitation (CPR)
Lethal Arrythmias
Others
By Product Type Devices
Accessories
By Algorithm Cardiac Arrest
Acute Coronary Syndromes
Bradycardia
Tachycardia
Suspected Stroke Algorithms
Others
By End User Hospitals and Clinics
Emergency Medical Services
Medical Training Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America

Key Questions Answered in the Report

How big is the Advanced Cardiovascular Life Support Market?

The Advanced Cardiovascular Life Support Market size is expected to reach USD 9.25 billion in 2027 and grow at a CAGR of 8.77% to reach USD 14.08 billion by 2032

What is the current Advanced Cardiovascular Life Support Market size?

In 2027, the Advanced Cardiovascular Life Support Market size is expected to reach USD 9.25 billion.

Who are the key players in Advanced Cardiovascular Life Support Market?

CPR Medical Devices, Inc., Abbott, GE HealthCare, Koninklijke Philips N.V. and Stryker are the major companies operating in the Advanced Cardiovascular Life Support Market.

Which is the fastest growing region in Advanced Cardiovascular Life Support Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2027-2032).

Which region has the biggest share in Advanced Cardiovascular Life Support Market?

In 2025, the North America accounts for the largest market share in Advanced Cardiovascular Life Support Market.

What years does this Advanced Cardiovascular Life Support Market cover, and what was the market size in 2024?

In 2024, the Advanced Cardiovascular Life Support Market size was estimated at USD 7.75 billion. The report covers the Advanced Cardiovascular Life Support Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Advanced Cardiovascular Life Support Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on: